Serum basic fibroblast growth factor in men with and without prostate carcinoma.
about
Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapiesPlasma levels of soluble CD105 correlate with metastasis in patients with breast cancerCellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.Angiogenesis in urological malignancy: prognostic indicator and therapeutic target.Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.The role of angiogenesis in prostate and other urologic cancers: a review.The role of the vascular phase in solid tumor growth: a historical review.Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer.Angiogenic tumor markers, antiangiogenic agents and radiation therapy.Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells.Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion frontCytokines as potential tumour markers.Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension.Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volumeBasic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expressionAndrogen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.Constitutive expression of FGF2/bFGF in non-tumorigenic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype.Positive and negative regulation of angiogenesis: from cell biology to the clinic.Immunohistochemical Expression of Angiogenic Factors by Neoplastic Epithelial Cells Is Associated With Canine Prostatic Carcinogenesis.Basic fibroblast growth factor protects against influenza A virus-induced acute lung injury by recruiting neutrophils.
P2860
Q28079232-2C1EA3CF-95D0-4C35-B8D6-38AF1092F0B0Q28141264-3D133A14-F1BD-42B5-B02A-4FE8C1DA5444Q30439922-8583FBE8-5B46-418E-8676-A3302D25310AQ33598141-CAF7E30B-28F5-476D-936B-C85D1571E957Q33607836-F59F281A-06F1-4D85-88AC-A76F53AAAAB3Q33955367-E7722842-802B-4C0E-842C-4201BEDED385Q33997842-560796CE-06E1-4F7B-A9E9-0F27DEF0796FQ34519166-FEED905E-2335-44F9-B747-3DAD0B6C26C2Q35160210-F16FC435-34D3-4211-9540-DE6A65DBAE6AQ35747992-DB4EF204-412C-4F1F-85D9-AE6E19715568Q36685324-A8ACE309-EF25-4920-9BFF-F4A57A425E97Q36848899-2CC51E6A-70AF-4778-8676-2FCC800D0FD9Q38089767-0C30E449-C48F-4F0E-BB25-87B3DDD06C64Q38111730-77742A31-94E4-4157-90ED-F410198495D9Q38274327-835D292D-2B53-4D51-B440-21945D2A2AC9Q38622783-FFC1FA37-01F2-4A70-82DA-B4C6EB1B4124Q40905901-F46165EF-D2C4-425F-AD0B-1DB5CE65FC0DQ41098573-5E79317B-741A-4D27-B8CD-B9A47A2A9A68Q41744346-500E1590-8ACF-4586-9272-1F72A9375B10Q42466619-73F728A0-88B0-4AB0-A5C6-89C5E61B4299Q45325042-9DB68D1E-D1A9-4A03-A35D-0C76C29AA77C
P2860
Serum basic fibroblast growth factor in men with and without prostate carcinoma.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Serum basic fibroblast growth factor in men with and without prostate carcinoma.
@en
type
label
Serum basic fibroblast growth factor in men with and without prostate carcinoma.
@en
prefLabel
Serum basic fibroblast growth factor in men with and without prostate carcinoma.
@en
P2093
P1433
P1476
Serum basic fibroblast growth factor in men with and without prostate carcinoma.
@en
P2093
P304
P356
10.1002/1097-0142(19951201)76:11<2304::AID-CNCR2820761119>3.0.CO;2-N
P407
P577
1995-12-01T00:00:00Z